Open Access Article
Makoto Shimizu
*ab,
Shingo Hatab,
Koichi Kondob,
Kazuhiro Murakamib,
Isao Mizota
b and
Yusong Zhua
aSchool of Energy Science and Engineering, Nanjing Tech University, Nanjing 211816, Jiangsu Province, China
bDepartment of Chemistry for Materials, Graduate School of Engineering, Mie University, Tsu, Mie 514-8507, Japan. E-mail: mshimizu@chem.mie-u.ac.jp
First published on 24th July 2020
While iminium salts generated by the oxidation of amino ketene silyl acetals show intriguing reactivities to give useful γ-oxo-α-amino esters via reactions with silyl enol ethers in good yields, new iminium salts are also prepared by the oxidation of amino silyl enol ethers. They undergo facile addition reaction with various nucleophiles to give α-amino ketone derivatives in good yields.
We have been interested in the generation of iminium salts and have already disclosed several intriguing features.4 In these studies, we focused on the generation of iminium species by oxidizing a readily accessible and stable enol derivative with oxidants and found that the alkoxycarbonyl iminium salts from amino ketene silyl acetals were reasonably stable5 and highly reactive to give addition products with metal cyanides, Grignard reagents, allyl metals,4b ketene silyl acetals,4g and indoles4c (eqn (1), Scheme 1). However, we have not fully studied reactions with silyl enol ethers, since an initial examination using the silyl enol ether derived from cyclopentanone met with a disappointing result where only a trace amount of the addition product was obtained. We now reexamined the reaction with other silyl enol ethers and found that an acceptable range of product yields was obtained under carefully controlled conditions. We did not study generation and reaction of the iminium salts derived from amino silyl enol ethers, either, although these iminium salts are highly attractive in terms of reactivity and chemoselectivity on an addition reaction with nucleophiles. This paper describes addition reactions of the alkoxycarbonyl iminium salts with silyl enol ethers to produce γ-oxo-α-amino esters (eqn (2)). Reactions of the iminium salts derived from amino silyl enol ethers with various nucleophiles are also presented to give addition products (eqn (3)).
Although an initial examination was carried out with the TMS enol ether derived from cyclopentanone, only a small amount of the desired addition product was obtained (entry 1). Switching the ring size from 5 to 6, 7, and 8 resulted in the formation of the desired products in 73, 71, and 68% yields, respectively (entries 2, 5, and 6). We next examined the effect of the silyl substituent on the diastereoselectivity.6 However, the use of bulky substituents such as TBS and TIPS did not improve the diastereoselectivity (entries 3 and 4). Reactions of acyclic silyl enol ethers were next examined. Table 2 summarizes the results.
| Entry | R | Si | Z/E | Solv. | Lewis acid | Yield (%)a | syn/anti |
|---|---|---|---|---|---|---|---|
| a Isolated yield.b Abbrebiation, DMS: dimethylsilyl. | |||||||
| 1 | Cy | TMS | 85/15 | EtCN | — | 3a: 32 | 52/48 |
| 2 | Cy | TMS | 85/15 | DMF | — | 3a: 67 | 77/23 |
| 3 | Cy | TMS | 85/15 | DME | BF3·Et2O | 3a: 22 | 76/24 |
| 4 | Cy | TBS | 85/15 | DMF | — | 3a: 62 | 78/22 |
| 5 | Cy | TBS | 85/15 | DME | BF3·Et2O | 3a: 25 | 65/35 |
| 6 | Ph | TMS | 90/10 | DME | BF3·Et2O | 3b: 57 | 57/43 |
| 7 | Ph | TMS | 90/10 | DME | Et2AlCl | 3b: 30 | 66/34 |
| 8 | Ph | TMS | 90/10 | DMF | — | 3b: 78 | 51/49 |
| 9 | Ph | TBS | 90/10 | DME | — | 3b: 8 | 60/40 |
| 10 | Ph | TBS | 90/10 | DME | BF3·Et2O | 3b: 38 | 58/42 |
| 11 | Ph | TBS | 90/10 | DME | Et2AlCl | 3b: 31 | 72/28 |
| 12 | Ph | TBS | 90/10 | DMF | — | 3b: 64 | 56/44 |
| 13 | Ph | TIPS | 85/15 | DME | — | 3b: 13 | 92/8 |
| 14 | Ph | TIPS | 85/15 | DME | BF3·Et2O | 3b: 60 | 86/14 |
| 15 | Ph | TIPS | 85/15 | DME | Et2AlCl | 3b: 30 | 88/12 |
| 16 | Ph | TIPS | 85/15 | DMF | — | 3b: 79 | 60/40 |
| 17 | Ph | DMSb | 88/12 | DME | — | 3b: 57 | 73/27 |
| 18 | Ph | DMS | 88/12 | DME | BF3·Et2O | 3b: 40 | 51/49 |
| 19 | Ph | DMS | 88/12 | DMF | — | 3b: 62 | 59/41 |
In terms of the product yields using the silyl enol ether derived from 1-cyclohexylpropan-1-one, the reaction in EtCN did not give a satisfactory result (entry 1), whereas the use of DMF in the absence of a Lewis acid gave better results (entries 2 and 4). The effects of a Lewis acid are not prominent on the diastereoselctivity, giving the addition products with moderate selectivities (entries 2 to 5).7 Regarding the silyl enol ether derived from propiophenone, both TMS and TIPS derivatives in DMF in the absence of a Lewis acid gave high yields of the product (entries 8 and 16). In general, the TIPS derivative recorded good syn-selectivities (entries 13 to 15). Among them the reaction in the presence of a Lewis acid (BF3·Et2O or Et2AlCl) gave the syn-adduct with good selectivities (entries 14 and 15), whereas the presence of a Lewis acid destroyed selectivities in certain cases (entries 6, 10, and 18). For the explanation of the syn-selectivity, Scheme 2 shows possible transition state models.
In the absence of a Lewis acid or in the presence of BF3·Et2O (monodentate Lewis acid), the non-chelation model would explain the preferred formation of the syn-isomer 3 due to the less steric congestion. In the cases where the reaction was carried out in the presence of Et2AlCl (bidentate Lewis acid), the chelation model would also support the formation of the syn-isomer 3. On the basis of the above transition state models, the formation of the syn-isomer 3 would be preferred regardless of the presence of Lewis acids.
During investigations into the reactivity of iminium salts 4 derived from amino ketene silyl acetals, new iminium salts from amino silyl enol ethers intrigued us (Scheme 3). However, no reliable reports are available for the generation of the iminium salts of type 6. We therefore investigated the generation of this type of iminium salt using a method similar to those from amino ketene silyl acetals.
The amino silyl enol ether 5 was readily prepared as follows in good yield (Scheme 4).
First, the formation of the iminium salt followed by addition reactions using the amino silyl enol ether 5 was examined to find the best reaction conditions involving the oxidation reagent and a Lewis acid. Table 3 summarizes the results. Iodosylbenzene did not effect the oxidation, while the use of BPO,4a NCS, and DBDMH gave the desired product in low yields (entries 1 to 4). DDQ4b,8 which was used for the oxidation of the amino ketene silyl acetal 1 effected the reaction to give the addition product 8a in 24% yield (entry 5). Among the oxidation reagents examined here the use of NBS recorded the best result (entry 6).4f We next examined the use of a Lewis acid for the present transformation. Et2AlCl was not effective, while an increased amount of the addition product was obtained in the presence of TiCl4 (entries 7 and 8). A better result was obtained when the reaction was carried out with NBS in the presence of BF3·Et2O, and the addition product was obtained in 74% yield (entry 9). The amounts of ketene silyl acetal and BF3·Et2O were further examined. The use of the reduced amounts of the ketene silyl acetal (1.5 equiv.) and BF3·Et2O (1.2 equiv.) gave a slightly better result (entry 10). Regarding the reaction temperature, the reaction at a higher temperature gave a reduced amount of the desired product (entry 13). The best result was obtained when the reaction was carried out with the ketene silyl acetal (1.5 equiv.) and BF3·Et2O (2.0 equiv.) at rt, and the addition product 8a was obtained in 80% yield (entry 15). Under the optimized conditions, various ketene silyl acetals were subjected to this addition reaction, and Table 4 summarizes the results.
| Entry | Oxidant | Nu (equiv.) | Lewis acid (equiv.) | Temp | Yielda (%) |
|---|---|---|---|---|---|
| a Isolated yield. | |||||
| 1 | PhIO | 2.0 | — | rt | 0 |
| 2 | BPO | 2.0 | — | rt | 7 |
| 3 | NCS | 2.0 | — | rt | 2 |
| 4 | DBDMH | 2.0 | — | rt | 10 |
| 5 | DDQ | 2.0 | — | rt | 24 |
| 6 | NBS | 2.0 | — | rt | 27 |
| 7 | NBS | 2.0 | Et2AlCl (2.0) | rt | 10 |
| 8 | NBS | 2.0 | TiCl4 (2.0) | rt | 48 |
| 9 | NBS | 2.0 | BF3·Et2O (2.0) | rt | 74 |
| 10 | NBS | 1.5 | BF3·Et2O (1.2) | rt | 76 |
| 11 | NBS | 1.5 | BF3·Et2O (1.5) | rt | 69 |
| 12 | NBS | 1.2 | BF3·Et2O (2.0) | rt | 53 |
| 13 | NBS | 1.5 | BF3·Et2O (2.0) | 50 °C | 40 |
| 14 | NBS | 1.5 | BF3·Et2O (2.0) | 0 °C to rt | 77 |
| 15 | NBS | 1.5 | BF3·Et2O (2.0) | rt | 80 |
As shown in Table 4, tetra-substituted ketene silyl acetals underwent addition reaction readily to give the adducts in good yields. Regarding the ester alkoxy part, methyl and ethyl esters were obtained in good yields (entries 1 and 2), whereas a bulky tbutyl derivative recorded a decreased yield of the product (entry 4). Di-substituted thioester also participated in the present addition to give the adduct in moderate yield (entry 7). We next examined the use of indole derivatives as nucleophiles, since indole skeletons are often found in many biologically active compounds such as tryptophan, indomethacin, and dragmacidin derivatives, and several methodologies have been reported to functionalize indoles.9 Table 5 summarizes the results.
N-TIPS indole was subjected to the present reaction conditions to give a moderate yield of the addition product 9a (entry 1). The best result was obtained when the reaction was conducted at 0 °C to rt for 5 h (entry 2). An electron-withdrawing group, 5-nitro substituent decreased the product yield considerably (entry 5), whereas 5-MeO, 5-Br, and 6-Br groups did not affect the addition reaction to give the adducts in good yields (entries 6 to 8). However, N–H free and N-Ts derivatives were not suitable for the present reaction, presumably due to the decreased electron-density at the 3-position of the indole skeleton (entries 9 and 10). We next examined the use of Grignard reagents as nucleophiles.
Treatment of the amino silyl enol ether 5 with NBS followed by ethylmagnesium bromide in the presence of BF3·Et2O actually gave the ethylated product 10b. Table 6 summarizes the optimization of reaction conditions.
As can be seen form Table 6, the best conditions were found when the amino silyl enol ether 5 was treated with NBS (1.1 equiv.) and ethylmagnesium bromide (2.0 equiv.) in the presence of BF3·Et2O (2.0 equiv.) in EtCN at rt for 30 min, and the ethylation product 10b was obtained in 74% yield (entry 4). Under the optimized conditions, a variety of Grignard reagents were subjected to the alkylation, and Table 7 summarizes the results.
| Entry | R | Product | Yielda (%) | Yieldb (%) |
|---|---|---|---|---|
| a RMgBr (2.0 equiv.) was used.b RMgBr (2.5 equiv.) was used.c BnMgCl was used. | ||||
| 1 | Me | 10a | 46 | 64 |
| 2 | Et | 10b | 74 | — |
| 3 | nPr | 10c | 71 | 62 |
| 4 | iPr | 10d | 63 | 63 |
| 5 | cPr | 10e | 27 | 35 |
| 6 | Cy | 10f | 58 | 60 |
| 7 | Bnc | 10g | 30 | 43 |
| 8 | Ph | 10h | 0 | 0 |
| 9 | 4-MeC6H4 | 10i | 46 | 38 |
| 10 | 2-Thienyl | 10j | 64 | 45 |
| 11 | Ethynyl | 10k | 0 | 0 |
Methyl, ethyl, npropyl, iso-propyl, cyclohexyl, and 2-thiehyl Grignard reagents recorded good product yields (entries 1–4, 6, and 10), whereas cylopropyl, benzyl, and 4-tolyl derivatives gave the addition products in moderate yields (entries 5, 6, and 9). However, phenyl and ethylnylmagnesium bromides did not give the desired products but gave complex mixtures (entries 8 and 11). Compared with the results obtained from the reactions of the iminium salts generated by the oxidation of amino ketene silyl acetals with Grignard reagents,4b this α-amino ketone-derived iminium salt appears to be only a little bit less reactive than ester-derived ones. Thus, the present iminium salt derived from α-amino ketone shows good reactivity as an electrophile to give a variety of addition products. The following Scheme 5 shows possible reaction pathways.
Regarding the formation of the iminium salt 4 derived from α-amino ester, DDQ oxidizes the amino ketene silyl acetal 1 to form the N,O-acetal 11, which collapses to form the iminium salt 4. This iminium salt 4 is responsible for the formation of the addition products with silyl enol ethers. In the case of α-amino ketone, NBS reacts with the amino silyl enol ether 5 to form the bromide 12. An activation with BF3·Et2O promotes the elimination of a Br ion to form the iminium salt 6, which reacts with a variety of nucleophiles.
:
nhexane = 6
:
1) to give the title compound (syn-2b (27.2 mg, 48%) and anti-2b (14.0 mg, 25%)).
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 1.02–1.61 (m, 6H including triplet at 1.40 ppm, J = 7.3 Hz, 3H), 1.86–2.05 (m, 2H), 2.26–2.35 (m, 2H), 2.59–2.63 (m, 1H), 2.96–2.98 (m, 1H), 3.37 (d, J = 13.7 Hz, 2H), 3.39 (d, J = 10.7 Hz, 1H), 3.86 (d, J = 13.7 Hz, 2H), 4.29 (dq, J = 7.3, 10.9 Hz, 1H), 4.30 (dq, J = 7.3, 10.9 Hz, 1H), 7.22–7.37 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 14.8, 25.2, 28.1, 31.1, 42.5 50.0, 54.8, 60.3, 60.5, 127.2, 128.4, 129.1, 139.2, 170.9, 212.2; IR (neat) 1712, 1637, 1453, 1176, 1150, 1030, 799, 700, 621, 496, 470, 438, 420 cm−1; HRMS (EI) calcd for C24H29NO3 (M)+ 379.2147, found 379.2164.
:
ethyl acetate = 5
:
1); 1H NMR (500 MHz, CDCl3) δ 1.35–1.81 (m, 10H including triplet at 1.56 ppm, J = 7.3 Hz), 2.02–2.05 (m, 1H), 3.04–3.08 (m, 1H), 3.32 (d, J = 13.1 Hz, 2H), 3.88 (d, J = 11.0 Hz, 1H), 3.96 (d, J = 13.1 Hz, 2H), 4.27 (dq, J = 7.3, 10.7 Hz, 1H), 4.35 (dq, J = 7.3, 10.7 Hz, 1H), 7.22–7.33 (m, 10H); 13C NMR (126 MHz, CDCl3) δ 14.8, 20.7, 28.0, 38.0, 49.5, 53.6, 54.5, 60.6, 61.2, 127.3, 128.5, 129.0, 139.2, 170.5, 219.0; IR (neat) 2860, 1710, 1638, 1494, 1451, 1373, 1335, 1307, 1233, 1175, 1135, 1027, 969, 794, 744, 699, 501 cm−1; HRMS (EI) calcd for C24H29NO3 (M)+ 379.2147, found 379.2148.
:
ethyl acetate = 5
:
1); 1H NMR (500 MHz, CDCl3) δ 1.41 (t, J = 7.0 Hz, 3H), 1.59–1.67 (m, 1H), 1.75–1.83 (m, 1H), 1.92–2.07 (m, 2H), 2.24–2.30 (m, 1H), 2.35–2.41 (m, 1H), 2.90–2.96 (m, 1H), 3.19 (d, J = 11.0 Hz, 1H), 3.36 (d, J = 13.7 Hz, 2H), 3.92 (d, J = 13.7 Hz, 2H), 4.28–4.41 (m, 2H), 7.23–7.39 (m, 10H); 13C NMR (126 MHz, CDCl3) δ 14.6, 20.5, 27.8, 37.9, 49.4 54.3, 60.4, 61.0, 127.2, 128.3, 128.8, 139.0, 170.3, 218.9; IR (neat) 3029, 2931, 1731, 1494, 1452, 1371, 1311, 1030, 966, 743, 698, 598 cm−1; HRMS (EI) calcd for C23H27NO3(M)+ 365.1991, found 365.2003.
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 0.85–0.99 (m, 1H), 1.09–1.18 (m, 1H), 1.21–1.40 (m, 5H including triplet at 1.38 ppm, J = 7.3 Hz, 3H), 1.60–1.94 (m, 4H), 2.23–2.32 (m, 1H), 2.53–2.60 (m, 1H), 3.08–3.15 (m, 1H), 3.45 (d, J = 13.8 Hz, 2H), 3.48 (d, J = 11.0 Hz, 1H), 3.85 (d, J = 13.8 Hz, 2H), 4.16–4.35 (m, 2H), 7.21–7.34 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 14.8, 23.3, 27.6, 28.7, 29.3, 43.6, 50.4, 55.6, 60.4, 61.9, 127.2, 128.4, 129.3, 139.2, 171.7, 215.0; IR (neat) 3029, 2929, 2853, 1453, 1375,1183, 1134, 1024, 938, 750, 700 cm−1; HRMS (EI) calcd for C25H31NO3 (M)+ 393.2304, found 393.2327.
:
ethyl acetate = 5
:
1); 1H NMR (500 MHz, CDCl3) δ 1.03–1.40 (m, 6H including a triplet at 1.38 ppm, J = 7.0 Hz, 3H), 1.56–1.79 (m, 5H), 2.02–2.15 (m, 2H), 3.13–3.21 (m, 1H), 3.28 (d, J = 13.3 Hz, 2H), 3.60 (d, J = 11.4 Hz, 1H), 3.96 (d, J = 13.3 Hz, 2H), 4.21–4.37 (m, 2H), 7.18–7.32 (m, 10H); 13C NMR (126 MHz, CDCl3) δ 14.8, 25.7, 26.8, 28.0, 29.6, 41.2, 52.3, 54.8, 60.5, 63.6, 127.2, 128.3, 129.4, 139.1, 169.9, 212.7; IR (neat) 3027, 2933, 2855, 1722, 1494, 1451, 1370, 1326, 1236, 1170, 1025, 750 cm−1; HRMS (EI) calcd for C25H31NO3 (M)+ 393.2304, found 393.2324.
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 0.92–0.95 (m, 1H), 1.08–1.13 (m, 1H), 1.17–1.26 (m, 1H), 1.37–1.57 (m, 9H including triplet at 1.38 ppm, J = 7.0 Hz, 3H), 1.69–1.73 (m, 1H), 2.00–2.04 (m, 1H), 2.14 (d,d,d, J = 2.8 Hz, 7.6 Hz, 15.1 Hz, 1H), 3.19 (d,t, J = 3.7 Hz, 10.6 Hz, 1H), 3.46 (d, J = 13.4 Hz, 2H), 3.58 (d, J = 10.6 Hz, 1H), 3.85 (d, J = 13.4 Hz, 2H), 4.17–4.32 (m, 2H), 7.23–7.34 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 14.7, 22.8, 24.4, 25.1, 28.5, 31.8 43.9, 48.0, 55.6, 60.4, 63.8, 127.2, 128.3, 129.3, 139.0, 171.8, 219.2; IR (neat) 2931, 2854, 1719, 1696, 1647,1454, 1027, 748, 698 cm−1; HRMS (EI) calcd for C26H33NO3 (M)+ 407.2460, found 407.2457.
:
ethyl acetate = 5
:
1); 1H NMR (500 MHz, CDCl3) δ 1.26–1.85 (m, 13H including a triplet at 1.38 ppm, J = 7.0 Hz, 3H), 2.04–2.19 (m, 2H), 3.25 (d, J = 13.7 Hz, 2H), 3.27 (d, J = 10.8 Hz, 1H), 3.56 (d, J = 11.6 Hz, 1H), 3.98 (d, J = 13.7 Hz, 2H), 4.21–4.37 (m, 2H), 7.22–7.34 (m, 10H); 13C NMR (126 MHz, CDCl3) δ 14.7, 24.6, 25.8, 26.1, 26.7, 28.9, 41.1, 50.4, 54.8, 60.3, 63.8, 127.1, 128.2, 129.2, 138.7, 170.0, 216.0; IR (neat) 2930, 1727, 1702, 1494, 1453, 1154, 1135, 1028, 749, 699 cm−1; HRMS (EI) calcd for C26H33NO3 (M)+ 407.2460, found 407.2460.
:
nhexane = 5
:
1) to give the title compound (syn-3a (32.5 mg, 52%) and anti-3a (9.7 mg, 15%)).10
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 0.86 (d, J = 6.9 Hz, 3H), 0.95–1.37 (m, 9H including a triplet at 1.29 ppm, J = 7.1 Hz, 3H), 1.61–1.82 (m, 4H), 2.14–2.22 (m, 1H), 3.22–3.31 (m, 3H including a doublet at 3.29 ppm, J = 14.2 Hz, 3H), 3.59 (d, J = 11.0 Hz, 1H), 3.95 (d, J = 14.2 Hz, 2H), 4.11–4.26 (m, 2H), 7.15–7.26 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 14.5, 15.0, 25.2, 25.8, 25.9, 28.0, 28.7, 43.7, 51.0, 55.2, 60.2, 65.0, 127.1, 128.2, 128.8, 138.5, 170.4, 213.9; IR (neat) 3027, 2933, 2852, 1728, 1711, 1495, 1450, 1375, 1027, 994, 732, 698 cm−1; HRMS (EI) calcd for C27H35NO3 (M)+ 421.2617, found 421.2623.
:
ethyl acetate = 5
:
1); 1H NMR (500 MHz, CDCl3) δ 0.97 (t, J = 7.1 Hz, 3H), 1.06 (d, J = 7.3 Hz, 3H), 1.37 (t, J = 7.1 Hz, 3H), 2.40–2.58 (m, 2H), 3.01–3.09 (m, 1H), 3.45 (d, J = 13.3 Hz, 2H), 3.53 (d, J = 11.0 Hz, 1H), 3.85 (d, J = 13.3 Hz, 2H), 4.14–4.32 (m, 2H), 7.22–7.36 (m, 10H); 13C NMR (126 MHz, CDCl3) δ 17.6, 14.6, 14.8, 34.9, 45.1, 55.2, 60.4, 62.7, 127.2, 128.3, 129.2, 138.9, 171.9, 214.0; IR (neat) 2931, 2851, 1725, 1495, 1452, 1368, 1027, 914, 698 cm−1; HRMS (EI) calcd for C27H35NO3 (M)+ 421.2617, found 421.2619.
:
anti = 57
:
43, ratio determined by 1H NMR). Yellow oil; Rf = 0.52 (nhexane
:
ethyl acetate = 5
:
1); IR (neat) 3061, 2979, 1724, 1683, 1495, 1027, 748, 698 cm−1; HRMS (EI) calcd for C27H29NO3 (M)+ 415.2147, found 415.2136.
:
AcOEt
:
Et3N = 20
:
1
:
1.1) to give the title amino silyl enol ether 5 (89%, 4.84 g, E
:
Z = 89
:
11).
Yield 89% (4.84 g); yellow solid; mp = 55–56 °C; Rf = 0.75 (nhexane
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3): δ 0.15 (s, 6H), 1.11 (s, 9H), 4.33 (s, 4H), 5.82 (s, 1H), 7.32–7.45 (m, 15H); 13C NMR (100 MHz, CDCl3): δ −3.9, 18.3, 26.0, 55.8, 123.4, 124.5, 125.5, 126.9, 127.9, 128.2, 128.7, 133.1, 139.0, 140.4; IR (neat): 3059, 3031, 2926, 2854, 1649, 1453, 1349, 1257, 1162, 1058, 1024, 923, 749, 703 cm−1. HRMS (EI) calcd for C28H35NOSi (M)+ 429.2488, found 429.2500.
:
AcOEt = 6
:
1) to give methyl 3-(dibenzylamino)-2,2-dimethyl-4-oxo-4-phenylbutanoate 8a (80%, 33.4 mg).
Yield 80% (33.4 mg); white solid; mp = 73−74 °C; Rf = 0.48 (nhexane
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 1.11 (s, 3H), 1.44 (s, 3H), 3.26 (d, J = 14.4 Hz, 2H), 3.49 (s, 3H), 4.01 (d, J = 14.4 Hz, 2H), 4.68 (s, 1H), 7.23–7.37 (m, 10H), 7.52–7.57 (m, 2H), 7.60–7.65 (m, 1H), 7.87–7.90 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 21.6, 25.6, 46.6, 51.8, 56.9, 64.4, 127.2, 128.2, 128.3, 128.7, 129.0, 132.8, 139.4, 141.2, 177.7, 202.1; IR (neat) 2949, 1729, 1678, 1451, 1268, 1145, 970, 745, 700 cm−1; HRMS (EI) calcd for C26H26NO2 (M-CH3O)+ 384.1958, found 384.1961.
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 1.06 (t, J = 7.3 Hz, 3H), 1.08 (s, 3H), 1.46 (s, 3H), 3.26 (d, J = 14.2 Hz, 2H), 3.90 (dq, J = 7.3, 10.5 Hz, 1H), 3.97–4.05 (m, 3H, including doublet at 4.01 ppm J = 14.2 Hz, 2H), 4.67 (s, 1H), 7.22–7.35 (m, 10H), 7.52–7.56 (m, 2H), 7.59–7.64 (m, 1H), 7.88–7.90 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 13.9, 21.3, 25.9, 46.5, 56.8, 60.5, 64.4, 127.2, 128.2, 128.4, 128.6, 129.0, 132.8, 139.4, 141.3, 177.3, 202.2; IR (neat): 3061, 3028, 2980, 2842, 1735, 1675, 1455, 1274, 1152, 968, 748, 699 cm−1; HRMS (EI) calcd for C26H26NO2 (M–C2H5O)+ 384.1958, found 384.1957.
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 1.01 (d, J = 6.4 Hz, 3H), 1.02 (s, 3H), 1.08 (d, J = 6.4 Hz, 3H), 1.49 (s, 3H), 3.26 (d, J = 14.2 Hz, 2H), 4.00 (d, J = 14.2 Hz, 2H), 4.64 (s, 1H), 4.84 (sept, J = 6.4 Hz, 1H), 7.22–7.36 (m, 10H), 7.52–7.56 (m, 2H), 7.60–7.64 (m, 1H), 7.88–7.91 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 20.7, 21.3, 21.6, 26.5, 46.4, 56.8, 64.5, 67.8, 127.2, 128.2, 128.4, 128.6, 129.0, 132.7, 139.4, 141.4, 176.9, 202.3; IR (neat): 3063, 3030, 2981, 2855, 1711, 1676, 1455, 1281, 1165, 1107, 970, 749, 694 cm−1; HRMS (EI): calcd for C26H26NO2 (M-C3H7O)+ 384.1958, found 384.1957.
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 0.98 (s, 3H), 1.27 (s, 9H), 1.47 (s, 3H), 3.28 (d, J = 14.2 Hz, 2H), 3.98 (d, J = 14.2 Hz, 2H), 4.62 (s, 1H), 7.22–7.37 (m, 10H), 7.51–7.56 (m, 2H), 7.59–7.63 (m, 1H), 7.88–7.90 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 20.6, 26.8, 27.8, 46.9, 56.7, 64.6, 80.5, 127.2, 128.2, 128.5, 128.6, 129.0, 132.6, 139.4, 141.5, 176.6, 202.4; IR (neat): 2976, 1678, 1456, 1247, 1146, 968, 848, 698 cm−1; HRMS (EI) calcd for C30H35NO3 (M)+ 457.2617, found 457.2607.
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 3.17 (s, 3H), 3.27 (s, 3H), 3.65 (d, J = 13.7 Hz, 2H), 3.71 (s, 3H), 4.26 (d, J = 13.7 Hz, 2H), 4.92 (s, 1H), 7.17–7.28 (m, 10H), 7.39–7.43 (m, 2H), 7.53–7.57 (m, 1H), 7.76–7.79 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 51.0, 51.2, 52.5, 55.5, 63.4, 103.8, 127.0, 128.0, 128.2, 128.8, 129.4, 132.9, 139.1, 139.6, 168.4, 200.9; IR (neat) 2950, 2821, 1757, 1681, 1547, 1214, 1073, 749, 696 cm−1; HRMS (EI) calcd for C27H29NO5 (M)+ 447.2046, found 447.2047.
:
ethyl acetate = 5
:
1); δ 1H NMR (400 MHz, CDCl3): δ 1.06 (t, J = 6.9 Hz, 6H), 1.20 (t, J = 7.3 Hz, 3H), 3.30–3.40 (m, 2H), 3.48 (dq, J = 6.9, 9.1 Hz, 1H), 3.61 (dq, J = 6.9, 9.1 Hz, 1H), 3.72 (d, J = 13.7 Hz, 2H), 4.05 (dq, J = 7.3, 10.5 Hz, 1H), 4.23–4.32 (m, 3H, including doublet at 4.27 ppm J = 13.7 Hz, 2H), 4.89 (s, 1H), 7.20–7.27 (m, 10H), 7.35–7.39 (m, 2H), 7.49–7.53 (m, 1H), 7.72–7.74 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 13.9, 14.8, 15.1, 55.5, 58.9, 59.2, 61.5, 64.7, 103.0, 126.8, 127.8, 127.9, 128.8, 129.5, 132.4, 139.5, 139.9, 168.2, 201.5; IR (neat) 2979, 1750, 1682, 1559, 1452, 1249, 1122, 1062, 748, 696 cm−1; HRMS (EI) calcd for C28H30NO4 (M–C2H5O)+ 444.2169, found 444.2170.
:
ethyl acetate = 5
:
1); 1H NMR (400 MHz, CDCl3) δ 1.45 (s, 9H), 2.97 (dd, J = 3.6, 15.5 Hz, 1H), 3.30 (dd, J = 8.7, 15.5 Hz, 1H), 3.46 (d, J = 13.3 Hz, 2H), 3.66 (d, J = 13.3 Hz, 2H), 4.83 (dd, J = 3.6, 8.7 Hz, 1H), 7.10–7.13 (m, 4H), 7.23–7.32 (m, 8H), 7.47–7.50 (m, 1H), 7.51–7.56 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 29.8, 38.3, 48.2, 54.5, 59.0, 127.3, 128.1, 128.2, 129.0, 129.3, 132.7, 136.4, 138.5, 198.6, 198.9; IR (neat) 3061, 3028, 2980, 2842, 1735, 1675, 1455, 1274, 1152, 968, 748, 699 cm−1; HRMS (EI) calcd for C28H31NO2S (M)+ 445.2076, found 445.2077.
:
AcOEt = 6
:
1) to give 2-(dibenzylamino)-1-phenyl-2-[1-(triisopropylsilyl)-1H-indol-3-yl]ethanone 9a (77%, 90.7 mg).
Yield 77% (90.7 mg); yellow oil; Rf = 0.61 (nhexane
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.95 (d, J = 7.3 Hz, 9H), 0.99 (d, J = 7.3 Hz, 9H), 1.55 (sept, J = 7.3 Hz, 3H), 3.94 (d, J = 13.7 Hz, 2H), 4.02 (d, J = 13.7 Hz, 2H), 5.78 (s, 1H), 6.91 (s, 1H), 7.16–7.30 (m, 14H), 7.34–7.37 (m, 1H), 7.44–7.46 (m, 1H), 7.65–7.68 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 12.6, 17.8, 17.9, 54.8, 59.8, 113.0, 113.9, 119.5, 119.9, 121.9, 126.7, 128.0, 128.1, 128.2, 129.1, 130.6, 132.5, 137.0, 140.6, 141.4, 201.7; IR (neat) 3060, 3026, 2948, 2868, 1685, 1494, 1449, 1165, 1144, 1074, 967, 882, 746, 696, 664 cm−1; HRMS (EI) calcd for C39H46N2OSi (M)+ 586.3380, found 586.3379.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.92–1.00 (m, 18H), 1.49–1.60 (m, 3H), 3.96 (dd, J = 13.8, 29.1 Hz, 4H), 5.80 (s, 1H), 7.04–8.65 (m, 19H); 13C NMR (100 MHz, CDCl3) δ 12.5, 17.7, 17.8, 54.8, 59.0, 113.7, 115.5, 116.8, 117.6, 127.1, 128.1, 128.4, 128.5, 129.1, 130.3, 133.0, 135.2, 136.9, 140.0, 141.9, 144.5, 201.2; IR (neat) 3064, 3025, 2945, 2866, 1683, 1508, 1447, 1338, 1264, 1206, 1136, 970, 808, 688, 659 cm−1; HRMS (EI) calcd for C30H39N3O3Si (M)+ 631.3230, found 631.3239.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.92 (d, J = 7.6 Hz, 9H), 0.96 (d, J = 7.6 Hz, 9H), 1.50 (sept, J = 7.6 Hz, 3H), 3.89 (s, 3H), 3.99 (s, 4H), 5.73 (s, 1H), 6.80–6.83 (m, 2H), 7.05–7.07 (m, 1H), 7.18–7.33 (m, 13H), 7.38–7.40 (m, 1H), 7.68–7.70 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 12.5, 17.8, 17.9, 54.7, 55.7, 60.0, 99.9, 100.9, 112.3, 113.1, 114.7, 126.8, 128.1, 128.3, 129.3, 131.1, 132.5, 133.0, 136.2, 137.1, 140.9, 154.2, 202.0; IR (neat) 3061, 3027, 2950, 2867, 1674, 1618, 1485, 1447, 1216, 1038, 1019, 884, 794, 744, 693, 660, 583 cm−1; HRMS (EI) calcd for C40H48N2O2Si (M)+ 616.3485, found 616.3482.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.94–0.99 (m, 18H), 1.53 (q, J = 7.6 Hz, 3H), 3.97 (dd, J = 13.6, 32.2 Hz, 4H), 5.71 (s, 1H), 6.92 (s, 1H), 7.15–7.48 (m, 16H), 7.68–7.79 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 12.6, 17.9, 18.0, 54.8, 59.5, 113.0, 113.5, 115.4, 122.4, 124.9, 127.1, 128.2, 128.3, 128.5, 129.3, 132.6, 132.8, 133.6, 137.0, 140.1, 140.5, 201.5; IR (neat) 3061, 3026, 2947, 2867, 1688, 1597, 1495, 1445, 1199, 1159, 1135, 967, 881, 795, 750, 718, 701, 689, 653, 567 cm−1; HRMS (EI) calcd for C30H39N2OSiBr (M)+ 664.2485, found 664.2452.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.88–1.09 (m, 18H), 1.47–1.59 (m, 3H), 3.96 (dd, J = 13.7, 34.8 Hz, 4H), 5.73 (s, 1H), 6.84–7.68 (m, 18H); 13C NMR (100 MHz, CDCl3) δ 3047, 2948, 2868, 1686, 1599, 1456, 1151, 1073, 967, 883, 814, 750, 695, 599; IR (neat) 3047, 2948, 2868, 1686, 1599, 1456, 1151, 1073, 967, 883, 814, 750, 695, 599 cm−1; HRMS (EI) calcd for C30H39N2OSiBr (M)+ 664.2485, found 664.2488.
:
AcOEt = 15
:
1) to give 2-(dibenzylamino)-1-phenylbutan-1-one 10b (74%, 25.5 mg).
Yield 74% (25.5 mg); colorless oil; Rf = 0.63 (nhexane
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.93 (t, J = 7.3 Hz, 3H), 1.80–1.89 (m, 1H), 1.93–2.02 (m, 1H), 3.69 (s, 4H), 4.14 (dd, J = 4.9, 8.5 Hz, 1H), 7.20–7.34 (m, 12H), 7.48–7.52 (m, 1H), 7.56–7.58 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 11.5, 17.8, 54.3, 62.6, 127.0, 128.2, 128.2, 128.5, 129.1, 132.6, 137.7, 139.6, 201.4; IR (neat): 3062, 3026, 2978, 2936, 2835, 1684, 1494, 1448, 1378, 1225, 1143, 936, 749, 732, 695 cm−1; HRMS (EI) calcd for C18H20NO (M–C6H5)+ 238.1590, found 238.1589.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 1.34 (d, J = 6.6 Hz, 3H), 3.54 (d, J = 13.5 Hz, 2H), 3.68 (d, J = 13.5 Hz, 2H), 4.34 (q, J = 6.6 Hz, 1H), 7.15–7.34 (m, 12H), 7.48–7.52 (m, 1H), 7.58–7.61 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 8.4, 54.3, 57.2, 127.1, 128.0, 128.2, 128.8, 129.2, 132.5, 136.9, 139.3, 202.0; IR (neat) 3062, 3026, 2978, 2936, 2835, 1684, 1494, 1448, 1378, 1225, 1143, 936, 749, 732, 695 cm−1; HRMS (EI) calcd for C17H18NO (M–C6H5)+ 224.1434, found 224.1438.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.92 (t, J = 7.3 Hz, 3H), 1.29–1.39 (m, 2H), 1.74–1.82 (m, 1H), 1.88–1.97 (m, 1H), 3.70 (s, 4H), 4.24 (dd, J = 5.5, 8.7 Hz, 1H), 7.21–7.34 (m, 12H), 7.48–7.58 (m, 3H). 13C NMR (100 MHz, CDCl3): δ 14.2, 20.1, 27.0, 54.3, 60.5, 127.0, 128.2, 128.2, 128.5, 129.1, 132.6, 137.5, 139.7, 201.7. IR (neat): 3061, 3028, 2957, 2832, 1684, 1494, 1447, 1373, 1245, 1209, 1072, 947, 751, 695 cm−1. HRMS (EI): calcd for C19H22NO (M–C6H5)+ 252.1747, found 252.1753.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 0.75 (d, J = 6.7 Hz, 3H), 1.24 (d, J = 6.7 Hz, 3H), 2.35–2.46 (m, 1H), 3.34 (d, J = 14.7 Hz, 2H), 4.02 (d, J = 10.4 Hz, 1H), 4.04 (d, J = 14.7 Hz, 2H), 7.21–7.29 (m, 10H), 7.37–7.40 (m, 2H), 7.54–7.57 (m, 1H), 7.65–7.67 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 20.3, 20.4, 27.8, 54.3, 65.4, 126.9, 128.1, 128.2, 128.5, 128.6, 133.0, 139.6, 139.9, 203.1; IR (neat): 3059, 3032, 2979, 2950, 2840, 1668, 1494, 1444, 1218, 1093, 976, 839, 737, 730, 699 cm−1; HRMS (EI) calcd for C19H22NO (M–C6H5)+ 252.1747, found 252.1741.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ −0.02–0.04 (m, 1H), 0.51–0.58 (m, 2H), 0.75–0.84 (m, 1H), 1.28–1.37 (m, 1H), 3.45 (d, J = 9.6 Hz, 1H), 3.79 (d, J = 13.8 Hz, 2H), 3.94 (d, J = 13.8 Hz, 2H), 7.20–7.36 (m, 12H), 7.50–7.61 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 2.9, 5.3, 8.5, 54.7, 66.7, 127.0, 128.1, 128.2, 128.6, 129.0, 132.7, 137.5, 139.8, 201.7; IR (neat) 3081, 3027, 2927, 2840, 1681, 1597, 1495, 1450, 1220, 744, 696 cm−1; HRMS (EI) calcd for C19H20NO (M–C6H5)+ 250.1590, found 250.1591.
:
ethyl acetate = 6
:
1); 1H NMR (500 MHz, CDCl3) δ 0.76–0.84 (m, 1H), 1.04–1.37 (m, 5H), 1.54–1.56 (m, 1H), 1.63–1.66 (m, 1H), 1.79–1.83 (m, 1H), 2.09–2.17 (m, 1H), 2.42–2.45 (m, 1H), 3.36 (d, J = 14.7 Hz, 2H), 4.05 (d, J = 14.7 Hz, 2H), 4.16 (d, J = 10.4 Hz, 1H), 7.22–7.39 (m, 12H), 7.52–7.55 (m, 1H), 7.63–7.65 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 26.0, 26.1, 26.6, 30.4, 31.0, 37.4, 54.3, 64.2, 126.8, 128.1, 128.2, 128.5, 128.6, 133.0, 139.6, 139.9, 203.4; IR (neat) 3061, 3028, 2926, 2850, 1675, 1494, 1446, 1234, 1201, 907, 844, 735, 698 cm−1; HRMS (EI): calcd for C22H26NO (M–C6H5)+ 292.2060, found 292.2056.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3): δ 3.12 (dd, J = 4.3, 13.4 Hz, 1H), 3.36 (dd, J = 9.2, 13.4 Hz, 1H), 3.71 (d, J = 13.4 Hz, 2H), 3.78 (d, J = 13.4 Hz, 2H), 4.54 (dd, J = 4.3, 9.2 Hz, 1H), 7.12–7.14 (m, 5H), 7.18–7.27 (m, 12H), 7.43–7.47 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 30.2, 54.3, 62.9, 126.0, 127.2, 128.1, 128.2, 128.3, 128.6, 129.2, 129.5, 132.6, 137.3, 139.1, 139.2, 199.7; IR (neat) 3060, 3025, 2931, 2815, 1688, 1600, 1494, 1455, 1233, 1116, 1072, 1027, 957, 750, 700 cm−1; HRMS (EI) calcd for C23H22NO (M–C6H5)+ 300.1747, found 300.1761.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 2.30 (s, 3H), 3.75 (d, J = 13.7 Hz, 2H), 3.96 (d, J = 13.7 Hz, 2H), 5.43 (s, 1H), 7.11–7.31 (m, 16H), 7.42–7.44 (m, 1H), 7.67–7.69 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 21.1, 54.4, 66.5, 126.9, 128.2, 128.3, 128.4, 128.9, 129.2, 129.9, 132.8, 133.3, 136.9, 137.5, 140.1, 201.7; IR (neat): 3059, 3026, 2922, 2844, 1689, 1595, 1494, 1447, 1226, 1138, 961, 804, 747, 700 cm−1; HRMS (EI): calcd for C23H22NO (M–C6H5)+ 300.1747, found 300.1744.
:
ethyl acetate = 6
:
1); 1H NMR (400 MHz, CDCl3) δ 3.67 (d, J = 13.7 Hz, 2H), 3.91 (d, J = 13.7 Hz, 2H), 5.69 (s, 1H), 6.90–6.92 (m, 1H), 6.96–6.99 (m, 1H), 7.23–7.37 (m, 13H), 7.48–7.52 (m, 1H), 7.67–7.69 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 54.5, 61.3, 126.3, 126.5, 127.1, 128.3, 128.4, 128.6, 129.0, 133.1, 136.5, 137.5, 139.4, 198.9. IR (neat): 3061, 3027, 2928, 2840, 1685, 1595, 1494, 1447, 1214, 957, 750, 699 cm−1; HRMS (EI) calcd for C20H18NOS (M–C6H5)+ 292.1154, found 292.1140.
Footnote |
| † Electronic supplementary information (ESI) available. See DOI: 10.1039/d0ra05768a |
| This journal is © The Royal Society of Chemistry 2020 |